View drug registration information details.


ItemsRegistration information
ID512
No512
Brand NameGAVISCON DUAL ACTION LIQUID
IngredientsSODIUM ALGINATE 500 MG, SODIUM BICARBONATE 213 MG, CALCIUM CARBONATE 325 MG
Dosage FormSUSPENSION
Primary PackagingSACHET, BOTTLE
StorageDO NOT STORE ABOVE 30C
Shelf Life2 YEARS
Pack SizeBOX OF 24 SACHETS X 10ML, BOX OF 150 ML/BOTTLE
Dispensing CategoryPrescription only
ATC ClassificationA02BX
Pharmaceutical ClassANTACIDS, ANTIULCERANTS
IndicationsTREATMENT OF SYMPTOMS RESULTING FROM THE REFLUX OF ACID, BILE AND PEPSIN INTO THE OESOPHAGUS SUCH AS ACID REGURGITATION, HEARTBURN AND INDIGESTION, FOR EXAMPLE FLLOWING MEALS OR DURING PREGNANCY, AND FOR SYMOMS OF EXCESS STOMACH ACID, CAN ALSO BE USED TO TREAT THE SYMPTOMS OF GASTRO-ESOPHAGEAL REFLUX DURING CONCOMITANT TREATMENT WITH OR FOLLOWING WITHDRAWAL OF ACID SUPPRESSION THERAPY
ContraindicationsHYPERSENSITIVITY TO ACTIVE INGREDIENT, MODERATE OR SEVERE RENAL INSUFFICIENCY
Side EffectsANAPHYLACTIC REACTION, ANAPHYLACTOID REACTION, URTICARIA, BROMCHOSPASM
Unit Price
EDL No
DescriptionOPAQUE OFF-WHITE TO CREAM VISCOUS SUSPENSION
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerRECKITT BENCKISER HEALTHCARE(UK)LIMITED
CountryUNITED KINGDOM
Import Registration NoPL00063/0552
Import Registration Date2008-06-25
ActivityCERTIFICATE RELEASED
Applied Date2021-04-02
FDD Registration No01 I 5372/23
FDD Registration Date2023-01-23
Expiry Date2026-01-22

Back to drug list